Click to Share
 
 
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
None Found
News By Tag
Inc. Treatment Remove


April 2015
Su Sa Fr Th We Tu Mo
19 18 17 16 15 14 13

Inc. Treatment Press Releases

 



By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Review of Blockbuster RA Vaccine RAVAX Phase 2B 340 Patient Study Results Demonstrated a 50% Improvement in Patients Vaccinated with RAVAX.
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Provides Blockbuster RAVAX Phase III Study in RA Update With Inadequate Response to Humira or Enbrel now Available at www.immuneresponse.net


Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share